Home LiteratureArticle Details
PMID: 11978814 Published · ppublish English Journal Article

Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition.

Savage MJ, Lin YG, Ciallella JR, Flood DG, Scott RW

Abstract

The mechanisms by which neurons and synapses are lost in Alzheimer's disease (AD) are not completely understood. To characterize potential signaling events linked to AD pathogenesis, activation-specific antibodies were used to examine mitogen-activated protein kinase (MAPK) kinase pathways at various ages in mice transgenic for human amyloid precursor protein-695 with the Swedish familial AD mutations (Tg2576) and homozygous for a P264L familial AD mutation introduced by targeting of the presenilin-1 gene (PS1(P264L)). Although the c-Jun N-terminal kinase (JNK) and p38 pathways were significantly activated in the cortex at both 7 and 12 months of age, there was no significant activation of the extracellular signal-regulated kinase pathway. MAPK kinase-4, an upstream activator of JNK, was also significantly activated at 7 and 12 months, whereas c-Jun, a downstream effector of JNK-associated apoptotic signaling, was not induced. The lack of c-Jun activation is consistent with the absence of neuronal loss in both cortex and hippocampal CA1 at 12 months. The JNK activation was localized to amyloid deposits, within neurites containing phosphorylated tau. Synaptophysin was quantified biochemically as a measure of synaptic integrity and was significantly reduced in an age-dependent manner in the Tg2576/PS1(P264L) cortex but not in either PS1(P264L) or Tg2576 cortex. Stress-responsive MAP kinase pathways were activated in the brain of the Tg2576/PS1(P264L) AD model, and this activation was coincident with the age-dependent increase in amyloid deposition, tau phosphorylation, and loss of synaptophysin.

MeSH Terms
Aging/metabolism Alzheimer Disease/genetics,metabolism,pathology Amino Acid Substitution Amyloid/metabolism Amyloid beta-Protein Precursor/genetics Animals Cell Count Cerebral Cortex/metabolism,pathology Disease Models, Animal Enzyme Activation Gene Targeting Hippocampus/pathology Humans Immunohistochemistry JNK Mitogen-Activated Protein Kinases Membrane Proteins/genetics Mice Mice, Transgenic Mitogen-Activated Protein Kinases/metabolism Neurites/enzymology,pathology Neurons/pathology Phosphorylation Presenilin-1 Signal Transduction Synaptophysin/deficiency,metabolism p38 Mitogen-Activated Protein Kinases tau Proteins/metabolism
Chemicals
Amyloid Amyloid beta-Protein Precursor Membrane Proteins PSEN1 protein, human Presenilin-1 Synaptophysin tau Proteins JNK Mitogen-Activated Protein Kinases Mitogen-Activated Protein Kinases p38 Mitogen-Activated Protein Kinases
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Savage Mary J
Department of Neurobiology, Cephalon Inc., West Chester, Pennsylvania 19380, USA. [email protected]
Lin Yin-Guo
Ciallella John R
Flood Dorothy G
Scott Richard W
References (59)
59 references, click to expand
  1. Dual roles for c-Jun N-terminal kinase in developmental and stress responses in cerebellar granule neurons.
    J Neurosci. 2000 Oct 15;20(20):7602-13 PMID: 11027220
  2. Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease.
    J Neurochem. 2001 Jan;76(2):435-41 PMID: 11208906
  3. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.
    J Neurosci. 2000 Jun 1;20(11):4050-8 PMID: 10818140
  4. Inflammation and Alzheimer's disease.
    Neurobiol Aging. 2000 May-Jun;21(3):383-421 PMID: 10858586
  5. Immunolocalization of the mitogen-activated protein kinases p42MAPK and JNK1, and their regulatory kinases MEK1 and MEK4, in adult rat central nervous system.
    J Comp Neurol. 1998 Aug 31;398(3):373-92 PMID: 9714150
  6. Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease.
    J Neuropathol Exp Neurol. 2000 Oct;59(10):880-8 PMID: 11079778
  7. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease.
    Ann Neurol. 1997 Jan;41(1):17-24 PMID: 9005861
  8. Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase pathway.
    J Biol Chem. 1997 Feb 7;272(6):3296-301 PMID: 9013568
  9. Unbiased stereological estimation of the number of neurons in the human hippocampus.
    J Comp Neurol. 1990 Jun 1;296(1):1-22 PMID: 2358525
  10. Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury.
    J Neurosci. 1998 Jul 15;18(14):5124-35 PMID: 9651196
  11. Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability.
    J Neurosci. 2000 Dec 1;20(23):8717-26 PMID: 11102478
  12. Negative regulation of the SAPK/JNK signaling pathway by presenilin 1.
    J Cell Biol. 2001 Apr 30;153(3):457-63 PMID: 11331298
  13. Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand.
    J Neurosci. 2001 Oct 1;21(19):7551-60 PMID: 11567045
  14. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases.
    FEBS Lett. 1997 Jun 2;409(1):57-62 PMID: 9199504
  15. Cathepsin G: localization in human cerebral cortex and generation of amyloidogenic fragments from the beta-amyloid precursor protein.
    Neuroscience. 1994 Jun;60(3):607-19 PMID: 7936190
  16. beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation.
    J Neurochem. 2001 Apr;77(1):157-64 PMID: 11279271
  17. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta.
    J Neurochem. 2000 Apr;74(4):1587-95 PMID: 10737616
  18. Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways.
    J Biol Chem. 1998 Feb 27;273(9):4928-36 PMID: 9478937
  19. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation.
    Physiol Rev. 2001 Apr;81(2):807-69 PMID: 11274345
  20. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease.
    J Neurosci. 2001 Jun 15;21(12):4125-33 PMID: 11404397
  21. JNK activation is associated with intracellular beta-amyloid accumulation.
    Brain Res Mol Brain Res. 2000 Dec 28;85(1-2):221-33 PMID: 11146125
  22. A requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation.
    J Biol Chem. 1997 Aug 1;272(31):19103-6 PMID: 9235897
  23. Plasma levels of amyloid beta proteins Abeta1-40 and Abeta1-42(43) are elevated in Down's syndrome.
    Ann Neurol. 1997 Feb;41(2):271-3 PMID: 9029078
  24. Mitogen-activated protein kinases activated by lipopolysaccharide and beta-amyloid in cultured rat microglia.
    Neuroreport. 1998 Mar 30;9(5):871-4 PMID: 9579682
  25. Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse.
    J Biol Chem. 2001 Sep 7;276(36):34298-306 PMID: 11441005
  26. Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation.
    Neuroreport. 1999 Aug 2;10(11):2411-5 PMID: 10439473
  27. p38 kinase is activated in the Alzheimer's disease brain.
    J Neurochem. 1999 May;72(5):2053-8 PMID: 10217284
  28. CEP-1347/KT-7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with Abeta-induced cortical neuron apoptosis.
    J Neurochem. 2001 May;77(3):849-63 PMID: 11331414
  29. c-Jun N-terminal kinase (JNK)-interacting protein-1b/islet-brain-1 scaffolds Alzheimer's amyloid precursor protein with JNK.
    J Neurosci. 2001 Sep 1;21(17):6597-607 PMID: 11517249
  30. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.
    Nat Med. 1996 Aug;2(8):864-70 PMID: 8705854
  31. Activation of MKK6, an upstream activator of p38, in Alzheimer's disease.
    J Neurochem. 2001 Oct;79(2):311-8 PMID: 11677259
  32. Brain Abeta amyloidosis in APPsw mice induces accumulation of presenilin-1 and tau.
    J Pathol. 2001 Aug;194(4):500-6 PMID: 11523060
  33. beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes.
    J Neurosci. 1998 Jun 15;18(12):4451-60 PMID: 9614222
  34. Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis.
    J Neuropathol Exp Neurol. 2001 Dec;60(12):1190-7 PMID: 11764091
  35. Structure, microtubule interactions, and phosphorylation of tau protein.
    Ann N Y Acad Sci. 1996 Jan 17;777:96-106 PMID: 8624133
  36. Mutations of the presenilin I gene in families with early-onset Alzheimer's disease.
    Hum Mol Genet. 1995 Dec;4(12):2373-7 PMID: 8634712
  37. Molecular mechanism of Alzheimer's neurofibrillary degeneration and therapeutic intervention.
    Ann N Y Acad Sci. 1996 Jan 17;777:132-8 PMID: 8624075
  38. Pathogenic mechanisms of Alzheimer's disease analyzed in the APP23 transgenic mouse model.
    Ann N Y Acad Sci. 2000;920:134-9 PMID: 11193142
  39. Familial Alzheimer's chromosome 14 mutations.
    Nat Med. 1995 Sep;1(9):848 PMID: 7585193
  40. Mammalian MAP kinase signalling cascades.
    Nature. 2001 Mar 1;410(6824):37-40 PMID: 11242034
  41. Peripheral axotomy induces long-term c-Jun amino-terminal kinase-1 activation and activator protein-1 binding activity by c-Jun and junD in adult rat dorsal root ganglia In vivo.
    J Neurosci. 1998 Feb 15;18(4):1318-28 PMID: 9454841
  42. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models.
    Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3228-33 PMID: 10077666
  43. Neurofibrillary pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.
    J Neuropathol Exp Neurol. 2001 Apr;60(4):357-68 PMID: 11305871
  44. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.
    Science. 1996 Oct 4;274(5284):99-102 PMID: 8810256
  45. FAD mutant PS-1 gene-targeted mice: increased A beta 42 and A beta deposition without APP overproduction.
    Neurobiol Aging. 2002 May-Jun;23(3):335-48 PMID: 11959395
  46. Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Brain Pathol. 2001 Apr;11(2):144-58 PMID: 11303790
  47. Neuron loss in APP transgenic mice.
    Nature. 1998 Oct 22;395(6704):755-6 PMID: 9796810
  48. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17.
    Nature. 1998 Jun 18;393(6686):702-5 PMID: 9641683
  49. Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes.
    J Neurosci. 1999 Apr 1;19(7):2706-16 PMID: 10087083
  50. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain.
    J Biol Chem. 1999 Mar 5;274(10):6483-92 PMID: 10037741
  51. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease.
    Lancet. 1994 Sep 17;344(8925):769-72 PMID: 7916070
  52. Structural correlates of cognition in dementia: quantification and assessment of synapse change.
    Neurodegeneration. 1996 Dec;5(4):417-21 PMID: 9117556
  53. CEP-1347 (KT7515), an inhibitor of JNK activation, rescues sympathetic neurons and neuronally differentiated PC12 cells from death evoked by three distinct insults.
    J Neurochem. 1999 Nov;73(5):1901-12 PMID: 10537048
  54. Increased immunoreactivity for Jun- and Fos-related proteins in Alzheimer's disease: association with pathology.
    Exp Neurol. 1994 Feb;125(2):286-95 PMID: 8313943
  55. Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation.
    Neuron. 1998 Oct;21(4):869-83 PMID: 9808472
  56. DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay.
    J Neurosci. 1996 Mar 1;16(5):1710-9 PMID: 8774439
  57. Phosphorylation of thr(668) in the cytoplasmic domain of the Alzheimer's disease amyloid precursor protein by stress-activated protein kinase 1b (Jun N-terminal kinase-3).
    J Neurochem. 2001 Jan;76(1):316-20 PMID: 11146006
  58. Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinase.
    J Neurosci. 2001 Jul 15;21(14):4987-95 PMID: 11438574
  59. CEP-1347/KT7515, a JNK pathway inhibitor, supports the in vitro survival of chick embryonic neurons.
    Neuroreport. 1998 May 11;9(7):1435-9 PMID: 9631443
Article Info
Journal
The Journal of neuroscience : the official journal of the Society for Neuroscience
Abbr.
J Neurosci
ISSN
1529-2401
Published
2002-05-01
Pages
3376-85
Language
English
Region
United States
NLM ID
8102140
PMCID
PMC6758401
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]